Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Brain Fog clinical trials

3 of 7 indexed Brain Fog trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Brain Fog: 7 US clinical trials tracked, 3 recruiting.

Brain Fog is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of California, Los Angeles, running 2 of these trials.

Enrollment posture brief

Registry condition brain-fog

OPEN 3 | RECR 43% | LATE 0 | EARLY 0 | RANK #2497 | SPON 2

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Brain Fog (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Brain Fog

Brain Fog lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Brain Fog on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Brain Fog is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Brain Fog research.

    University of California, Los Angeles accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Brain Fog trials plan to enrol fewer than 100 people.

    Median target enrolment is 31 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Brain Fog research is mostly interventional.

    6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Brain Fog records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Active Transcranial Direct Stimulation Device
1 trials
whole food - walnuts Other
1 trials
Placebo Product Dietary supplement
1 trials
Active Product Dietary supplement
1 trials
cross-sectional MRI and EEG assessments (NO INTERVENTION) Other
1 trials
Stasis Daytime and Nighttime Dietary supplement
1 trials
Follow Up Phone Calls Behavioral
1 trials
Transfer Package Behavioral
1 trials

US sites by state

Facility locations filed on Brain Fog trials. A trial with sites in several states counts in each.

California 4 trials
Texas 1 trials
Nevada 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Brain Fog page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Fog condition card totals 7 registered trials; most-linked intervention Active Transcranial Direct Stimulation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.